Lung Neoplasms: all 7,334 studies

Page 48 of 74. Open to participants first (1,555), then studies with results posted, then the rest; newest registration first within each.

• Optimal Extent of Pulmonary Resection in Clinical Stage IA Non-Small Cell Lung CancerActive, not recruitingNCT03066297
• Pre Radiotherapy Daily Exercise Training in Non-Small Cell Lung CancerStatus unknownNCT03066271Not applicable
• 89Zr-labeled Pembrolizumab in Patients With Non-small-cell Lung CancerStatus unknownNCT03065764Phase 2
• Zeushield Cytotoxic T Lymphocytes (Z-CTLs) for Relapsed or Refractory Non Small Cell Lung Cancer (NSCLC)Status unknownNCT03060343Early Phase 1
• Study of Anlotinib in Patients With Small Cell Lung Cancer (ALTER1202)CompletedNCT03059797Phase 2
• Immunotherapy as Second-line in Patient With Small Cell Lung CancerCompletedNCT03059667Phase 2
• Therapeutic ResistAnce and Clonal Evolution Assessed With Liquid Biopsy of NSCLC Patients in ChinaCompletedNCT03059641
• The Treatment of Advanced Lung Cancer With Dribbles Antigen by Targeting Activation of TcellsStatus unknownNCT03057340Phase 1
• Prognostic Evaluation of Tumor Volume and Its Changes in Radical Radiotherapy of Advanced NSCLCCompletedNCT03055715
• Adjuvant Pembrolizumab in N2 Positive Non-small Cell Lung Cancer PatientsStatus unknownNCT03053856Phase 2
• Clinical Application of MR-PET in Non-small Cell Lung Cancer: Diagnosis, Treatment Outcome, and Prognosis PredictionStatus unknownNCT03053804Not applicable
• Apatinib Combine With EGFR-TKI for Advanced EGFR-TKI-resistant Non-Small Cell Lung CancerStatus unknownNCT03050411Phase 1
• Magnetic Resonance Imaging (MRI) for the Delineation of Organs At Risk (OAR) and Target Volumes in Lung Cancer PatientsCompletedNCT03048760Not applicable
• A Safety Study of Nivolumab in Combination With Ipilimumab in Participants With Advanced Non-small Cell Lung CancerWithdrawnNCT03048136Phase 3
• A Pilot Study to Develop Predictive Biomarkers for the Response to Immunotherapy in Lung CancerCompletedNCT03047616
• Fostering Efficacy of Anti - PD-1 - Treatment: Nivolumab Plus Radiotherapy in Advanced NSCLCCompletedNCT03044626Phase 2
• Mapping Sound Propagation Through the Human Lung for Better DiagnosisTerminatedNCT03043898
• PixelShine vs. Iterative Reconstruction (IR) Processing of CT ImagesStatus unknownNCT03033615Not applicable
• Everolimus TDM to Predict Long Term ToxicityStatus unknownNCT03033186
• Immune Neoadjuvant Therapy Study of Durvalumab in Early Stage Non-small Cell Lung CancerTerminatedNCT03030131Phase 2
• Oncolytic Adenovirus-Mediated Gene Therapy for Lung CancerWithdrawnNCT03029871Phase 1
• PD-L1 and Other Immuno-markers Influenced by Osimertinib Treatment in Advanced NSCLC PatientsStatus unknownNCT03029858
• Intravenous and Intrathecal Nivolumab in Treating Patients With Leptomeningeal DiseaseActive, not recruitingNCT03025256Phase 1
• Nivolumab in Treating Patients With Stage IV or Recurrent Lung Cancer With High Mutation LoadsWithdrawnNCT03023904Phase 2
• Detection of Heterogeneity in Central Lung Cancer - EBUS-TBNA and ctDNA Analysis vs. Endobronchial Forceps BiopsyCompletedNCT03017183Not applicable
• Modifying Your Diet to Support Muscle During Cancer Treatment.CompletedNCT03010657Not applicable
• Effect of Pulmonary Rehabilitation on Perioperative Outcomes in Smoker Patients With Lung CancerStatus unknownNCT03010033Not applicable
• Olaparib Monotherapy in Relapsed Small Cell Lung Cancer Patients With HR Pathway Gene Mutations Not Limited to BRCA 1/2 Mutations, ATM Deficiency or MRE11A MutationsCompletedNCT03009682Phase 2
• ENB Guided RFA for Early-stage Peripheral Lung CancerStatus unknownNCT03009630Not applicable
• Endostar Plus EGFR-TKI（Epidermal Growth Factor Receptor-Tyrosine-Kinase Inhibitor） as a Treatment of EGFR Mutation-positive NSCLCStatus unknownNCT03008109Phase 3
• High-activity Natural Killer Immunotherapy for Small Metastases of Non-small Cell Lung CancerCompletedNCT03007875Phase 1/2
• Study of Split-course Chemoradiotherapy For Postoperative Locoregional Recurrence Of Non-small Cell Lung CancerStatus unknownNCT03006575Phase 2
• MEDI4736 With Selumetinib for KRAS Mutant Non-Small Cell Lung Cancer (NSCLC)WithdrawnNCT03004105Phase 2
• Complete Endosonographic Intrathoracic Nodal Staging of Lung Cancer Patients in Whom SABR is ConsideredStatus unknownNCT02997449
• Paclitaxel Liposome for Squamous Non-Small-cell Lung Cancer Study(LIPUSU)Status unknownNCT02996214Phase 4
• FLT-PET/DW-MRI for Detection of Brain Metastases and Early Therapy Evaluation in Patients With Small Cell Lung CancerCompletedNCT02995902Not applicable
• FLT-PET for Early Detection of Relapse in Patients With Irradiated Lung CancerCompletedNCT02995889Not applicable
• Study of Apatinib as Third-line and Later Therapy in Patients With Small Cell Lung Cancer (SCLC)Status unknownNCT02995187Phase 2
• Single-port, Two-port Versus Three-port VATS on Non-small Cell Lung CancerStatus unknownNCT02992353Not applicable
• Risk Factors of Medistinal Metastasis in Endoscopic Staging of Lung CancerActive, not recruitingNCT02991924
• Exercise Effect on Chemotherapy-Induced Neuropathic PainActive, not recruitingNCT02991677Not applicable
• Study of IRX4204 With Erlotinib in Previously Treated Advanced NSCLCTerminatedNCT02991651Phase 1
• Kentucky LEADS Collaborative: Lung Cancer Survivorship Care ProgramCompletedNCT02989974Not applicable
• Neoadjuvant Chemoradiation Plus Pembrolizumab Followed By Consolidation Pembrolizumab in NSCLCTerminatedNCT02987998Phase 1
• Oral Navelbine and Cisplatin Followed by Metronomic Oral Navelbine in Non-Small Cell Lung CancerTerminatedNCT02985203Phase 2
• Danvatirsen and Durvalumab in Treating Patients With Advanced and Refractory Pancreatic, Non-Small Cell Lung Cancer, and Mismatch Repair Deficient Colorectal CancerActive, not recruitingNCT02983578Phase 2
• Topotecan Plus Apatinib Versus Topotecan Alone as Second-line Therapy in Small-cell Lung CancerStatus unknownNCT02980809Phase 2
• Combining Radiosurgery and Nivolumab in the Treatment of Brain MetastasesCompletedNCT02978404Phase 2
• 99mTc/68Ga Labeled Anti-PD-L1 sdAb in Assessment of PD-L1 Expression in NSCLCCompletedNCT02978196Early Phase 1
• Effect of Qigong on the Symptom Clusters of Dyspnea, Fatigue, and Anxiety.CompletedNCT02977845Not applicable
• Imaging Multiparametric/Multimodality for LungcancerStatus unknownNCT02977663Not applicable
• To Evaluate the Role of Postoperative Radiotherapy in Patients With IIIA(N2) Non-Small Cell Lung CancerStatus unknownNCT02977169Phase 2
• [18F]HX4 PET/CT Imaging for Detection of HypoxiaCompletedNCT02976883Phase 2
• SBRT Combination With rhGM-CSF and Tα1 for Stage IV NSCLC Patients Who Failed in Second-line ChemotherapyStatus unknownNCT02976740Phase 2
• A Phase Ib Study of LXH254-centric Combinations in NSCLC or MelanomaTerminatedNCT02974725Phase 1
• To Evaluate the Optimal Timing of Postoperative Radiotherapy in Patients With IIIA(N2) Non-Small Cell Lung CancerTerminatedNCT02974426Phase 3
• Transbronchial Ablation for Peripheral Lung TumorStatus unknownNCT02972177Not applicable
• Clinical Study of YQ1 Plus Cisplatin-based Chemotherapy in Advanced NSCLC EGFR Wild TypeStatus unknownNCT02967497Phase 2
• Dynamic Changes of Circulating Tumor DNA in Surgical Lung Cancer PatientsCompletedNCT02965391
• The Value of VOCs Analysis in Exhaled Breath for Pulmonary Benign and Malignant Lesion DiagnosisStatus unknownNCT02965300
• Binimetinib in Addition to Standard Chemotherapy in KRAS Mutated NSCLC.CompletedNCT02964689Phase 1
• Effect Of Ketamine Infusion In Patients With COPD Applied One Lung VentilationCompletedNCT02962999Phase 4
• Development and Pilot Testing of a Clinical Informatics Lung Cancer Screening InterventionCompletedNCT02962115Not applicable
• Icotinib in Non-small Cell Lung Cancer Patients With Uncommon EGFR MutationStatus unknownNCT02961270Phase 2
• Ensartinib in Non-small Cell Lung Cancer Patients With Positive ALKCompletedNCT02959619Phase 1
• Chest Wall Motion Analysis in DiseaseCompletedNCT02958683
• Personalized DC Vaccine for Lung CancerStatus unknownNCT02956551Phase 1
• An Open-Label Study to Enable Continued Treatment Access for Subjects Previously Enrolled in Studies of RuxolitinibActive, not recruitingNCT02955940Phase 2
• CIMAvax Vaccine, Nivolumab, and Pembrolizumab in Treating Patients With Advanced Non-small Cell Lung Cancer or Squamous Head and Neck CancerActive, not recruitingNCT02955290Phase 1/2
• MRI Adaptive Replanning Using ViewRayWithdrawnNCT02950792Not applicable
• Stereotactic Body Radiation Therapy for Un-biopsied Early- Stage Non Small Cell Lung CancerActive, not recruitingNCT02950337Not applicable
• Study of Ibrutinib Followed by Ibrutinib in Combination With Nivolumab in Non-Small Cell Lung Cancer (NSCLC)WithdrawnNCT02950038Phase 2
• Study of BMS-986012 in Subjects With Small Cell Lung CanerCompletedNCT02949895Phase 1
• Nimotuzumab and Nivolumab in Treating Patients With Advanced Non-small Cell Lung CancerCompletedNCT02947386Phase 1
• ALK/ROS1/MET Mutations on Plasma ctDNA in Patients With NSCLCStatus unknownNCT02946216
• Apatinib for Extensive Stage Small Cell Lung Cancer After Second/Third Line Chemotherapy.CompletedNCT02945852Phase 2
• Audit of Lung Cancer Screening Practice in Chest Physicians: An UpdateCompletedNCT02944903
• Study of Veliparib in Combination With Nivolumab and Platinum Doublet Chemotherapy in Participants With Metastatic or Advanced Non-Small Cell Lung Cancer (NSCLC)CompletedNCT02944396Phase 1
• A Study of Gemcitabine-Carboplatin Plus Necitumumab (LY3012211) in Chemotherapy-Naïve Participants With Locally Advanced or Metastatic Squamous Non-Small Cell Lung Cancer (NSCLC)WithdrawnNCT02941601Phase 2
• Precision Diagnosis for Intraoperative Frozen Section of Early Stage Lung CancerStatus unknownNCT02941003Not applicable
• 18F-FDG Metabolism Imaging Monitoring Non-small Cell Lung Cancer Curative Effect of Chemotherapy Multicenter Clinical StudyStatus unknownNCT02938546Phase 3
• Bronchoscopy With Bronchoalveolar Lavage in Identifying Biomarkers of Response to Immune Checkpoint Inhibitors in Patients With Non-small Cell or Small Cell Lung CancerTerminatedNCT02937402Not applicable
• Study to Evaluate the Benefit of a High Frequency Ventilation System During Lung or Breast Cancer Radiotherapy TreatmentTerminatedNCT02936947Not applicable
• Precision Diagnosis and Therapy for Early Stage Lung CancerStatus unknownNCT02936804Not applicable
• Cohort of Patients With NSCLC Treated With Nivolumab Under the ATU ProgramCompletedNCT02933346
• Uniportal Versus Triportal Thoracoscopic Lobectomy and Sublobectomy for Early Stage Lung CancerStatus unknownNCT02933294Not applicable
• Changing Over Time of Ascorbic Acid After ChemotherapyStatus unknownNCT02931942
• Interest of Procore Needle® for Diagnosis of Lung CancerCompletedNCT02931461Not applicable
• A Study of Lorlatinib in Advanced ALK and ROS1 Rearranged Lung Cancer With CNS Metastasis in the Absence of Measurable Extracranial LesionsStatus unknownNCT02927340Phase 2
• Phase I/II Study of CK-101 in NSCLC Patients and Other Advanced Solid TumorsCompletedNCT02926768Phase 1
• A Study of RGX-104 in Patients With Advanced Lung & Endometrial CancerCompletedNCT02922764Phase 1
• Descriptive Analysis of G-CSF Use in Patients With Breast Cancer, Lung Cancer, or Lymphoma TreatedCompletedNCT02921191
• Open-label, Multicenter, Randomized Phase II Trial of Treatment With Cisplatin and Pemetrexed or Cisplatin and Oral Vinorelbine in Chemotherapy Naïve Patients Affected by Stage IIIB-IV Non-Squamous Non-Small Cell Lung Cancer With High Thymidylate Synthase ExpressionTerminatedNCT02919462Phase 2
• An Open-Label Phase 1/2 Study of Itacitinib in Combination With Osimertinib in Subjects With Non-Small Cell Lung CancerCompletedNCT02917993Phase 1/2
• Safety, Tolerability and Pharmacokinetic Profile of BPI-15086 in EGFR T790M Mutation-positive NSCLC PatientsCompletedNCT02914990Phase 1
• A Dose Finding and Expansion Study of RO7051790 Administered Orally in Participants With Relapsed, Extensive-Stage Disease Small Cell Lung Cancer (ED SCLC)CompletedNCT02913443Phase 1
• Real-Life Study With Nivolumab (BMS-936558) in Advanced NSCLC Patients After Prior ChemotherapyCompletedNCT02910999
• VATS Versus Open Pulmonary Lobectomy in the Limelight of OEPCompletedNCT02910453
• Continuation Study of Entinostat in Combination With Pembrolizumab in Patients With Advanced Solid TumorsCompletedNCT02909452Phase 1
• Urinary Circulating Tumor DNA Detection in Non-small Cell Lung Cancer: a Prospective StudyStatus unknownNCT02907606

← Lung Neoplasms overview